Search
Lilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products
June 20, 2024 - … and other unsafe or untested versions of our FDA-approved tirzepatide medications (Mounjaro ® and Zepbound ® ) and … compounded products containing what they claim is tirzepatide. In these actions, Lilly alleges that the … counterfeit products and unsafe or untested compounded tirzepatide put people at risk. Important takeaways from the …
An Open Letter From Eli Lilly and Company Regarding Certain Practices Related to Mounjaro® and Zepbound®
June 20, 2024 - … certain practices we are seeing from others related to our tirzepatide medicines—Mounjaro ® and Zepbound ® —to ensure … 18 Mounjaro ® and Zepbound ® Are The Only FDA-Approved Tirzepatide Medications Unsafe Online and Social Media Ads … Always Consult Your Healthcare Provider Non-Lilly Tirzepatide Can Put People At Risk Fake Products Unsafe …
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks
June 8, 2024 - … Lilly's tirzepatide was superior to placebo for MASH resolution, and … achieved improvement in fibrosis at 52 weeks Lilly's tirzepatide was superior to placebo for MASH resolution, and … type 2 diabetes, to evaluate the investigational use of tirzepatide in adults with biopsy-proven metabolic …
Lilly Statement on Mounjaro® (tirzepatide) Compounding Litigation
September 19, 2023 - … Lilly Statement on Mounjaro® (tirzepatide) Compounding Litigation Lilly Statement on Mounjaro® (tirzepatide) Compounding Litigation September 19, 2023 … safety or effectiveness of products claiming to contain tirzepatide that are not our own branded product. Because of …
Lilly Statement on Mounjaro® (tirzepatide) U.S. International Trade Commission Complaint
October 19, 2023 - … Lilly Statement on Mounjaro® (tirzepatide) U.S. International Trade Commission Complaint Lilly Statement on Mounjaro® (tirzepatide) U.S. International Trade Commission Complaint … selling, or distributing what those companies assert is tirzepatide, the active pharmaceutical ingredient (API) in …
Open Letter Regarding the Use of Mounjaro® (tirzepatide) and Zepbound® (tirzepatide)
March 7, 2024 - … Open Letter Regarding the Use of Mounjaro® (tirzepatide) and Zepbound® (tirzepatide) Open Letter Regarding the Use of Mounjaro® (tirzepatide) and Zepbound® (tirzepatide) March 7, 2024 … Open Letter Regarding the Use of Mounjaro® (tirzepatide) and Zepbound® (tirzepatide) …
Lilly Update on Mounjaro® and Zepbound® (tirzepatide) Compounding Litigation
May 14, 2024 - … Lilly Update on Mounjaro® and Zepbound® (tirzepatide) Compounding Litigation Lilly Update on Mounjaro® and Zepbound® (tirzepatide) Compounding Litigation May 14, 2024 Corporate … pharmacies or counterfeiters to be FDA-approved tirzepatide, Mounjaro ® , or Zepbound ® may expose patients …
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines
May 24, 2024 - … Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines Lilly Increases … Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines May 24, 2024 Corporate … active pharmaceutical ingredients (API) for Zepbound ® (tirzepatide) injection and Mounjaro ® (tirzepatide) injection …
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
April 30, 2024 - … included positive results from two Phase 3 trials of tirzepatide for obstructive sleep apnea; submission of … of the SURMOUNT-OSA Phase 3 clinical trials that showed tirzepatide significantly reduced the apnea-hypopnea index … Ingelheim ) Jaypirca ® (pirtobrutinib, Lilly) Mounjaro ® (tirzepatide injection, Lilly) Olumiant ® (baricitinib, Lilly) …
Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity
April 17, 2024 - … Tirzepatide reduced sleep apnea severity by up to nearly … in adults with obstructive sleep apnea (OSA) and obesity Tirzepatide reduced sleep apnea severity by up to nearly … apnea (OSA) and obesity April 17, 2024 Product General Tirzepatide achieved a mean apnea-hypopnea index reduction of …